Richard Jordan

4PUBLICATIONS

69CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Jun 25, 2026

Tumoral and Systemic Immune Correlates of Response to Concurrent Pembrolizumab and Chemoradiotherapy in Patients with Resected High-Risk Head and Neck Squamous Cell Carcinoma.

|Dec 01, 2025

A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer.

Sebastian Medina, Naoto Tokuyama, Kamal Hammouda

|Dec 10, 2024

Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic Cancer.

Li Guan, Pedro A Torres-Saavedra, Xiaobei Zhao

|Jan 27, 2019

Use of nonsteroidal anti-inflammatory drugs predicts improved patient survival for <i>PIK3CA</i>-altered head and neck cancer.

Matthew L Hedberg, Noah D Peyser, Julie E Bauman

Pageof 1

Frequent Collaborators

2 joint publications

Pedro Torres-Saavedra

Quynh-Thu Le

Jonathan Harris

Li Guan

Xiaobei Zhao

Michael B Major

Brittany J Holmes

Ngan K Nguyen

Robert L Ferris

Tim Hodge

Frequent Collaborators

2 joint publications

Pedro Torres-Saavedra

2 joint publications

Quynh-Thu Le

2 joint publications

Jonathan Harris

1 joint publications

Li Guan